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The TGFb/BMP signaling pathways are involved in glaucomatous damage to the trabecular meshwork
(TM) leading to elevated intraocular pressure (IOP), which is a major risk factor for the development and
progression of glaucoma. The BMP antagonist gremlin is elevated in glaucomatous TM cells and tissues
and can directly elevate IOP. Gremlin utilizes the TGFb2/SMAD pathway to induce TM extracellular
matrix (ECM) proteins. The purpose of this study is to determine whether expression of the ECM cross-
linking lysyl oxidase (LOX) genes is regulated by gremlin in cultured human TM cells. Human TM cells
were treated with recombinant gremlin, and expression of the LOX genes was examined by quantitative
RT-PCR and western immunoblotting. TM cells were pretreated with TGFBR inhibitors (LY364947 or
SB431542), an inhibitor of the SMAD signaling pathway (SIS3), or with JNK (SP600125) and p38 MAPK
(SB203580) inhibitors to identify the signaling pathway(s) involved in gremlin induction of LOX protein
expression. All ﬁve LOX genes (LOX and LOXL1e4) were induced by gremlin. Gremlin induction of LOX
genes and protein expression was blocked by TGFBR inhibitors as well as by inhibitors of the SMAD3, JNK
and p38 MAPK signaling pathways. We conclude that gremlin employs both canonical TGFb/SMAD and
the non-canonical JNK and p38 MAPK signaling pathways to induce LOX genes and proteins in cultured
human TM cells. Increased LOX levels may be at least partially responsible for gremlin-mediated IOP
elevation and increased aqueous humor outﬂow resistance leading to glaucoma.
 2013 The Authors. Published by Elsevier Ltd. All rights reserved.1. Introduction
Glaucoma is a leading cause of irreversible visual impairment
and blindness in the world, with primary open-angle glaucoma
(POAG) being the major form of glaucoma (Quigley and Broman,
2006). Elevated intraocular pressure (IOP) is a major risk factor
for the development and progression of glaucoma (AGIS, 2000;
Weinreb and Khaw, 2004). Ocular hypertension is attributed to
increased aqueous humor (AH) outﬂow resistance in the trabecular
meshwork (TM), a tissue in the anterior segment of the eye.
Elevated IOP has been associated with increased deposition ofr the terms of the Creative
Works License, which per-
ion in any medium, provided
University of Texas South-
Published by Elsevier Ltd. All righextracellular matrix (ECM) material within the TM. Therefore,
glaucoma can be viewed as a ﬁbrotic disorder of the TM.
Numerous studies have shown that TGFb2 levels are elevated in
the AH (Inatani et al., 2001; Tripathi et al., 1994) and TM of POAG
patients (Tovar-Vidales et al., 2011). TGFb2 is a proﬁbrotic growth
factor linked to ﬁbrotic diseases of the lung, kidney, skin, and liver.
TGFb2 has a number of effects on the TM, most notably increasing
AH outﬂow resistance and elevating IOP in perfusion cultured hu-
man and porcine eyes (Bachmann et al., 2006; Fleenor et al., 2006;
Gottanka et al., 2004) as well as in rodent eyes (Shepard et al.,
2010). TGFb2 also modulates TM ECM metabolism. This growth
factor increases the expression of a variety of ECM proteins,
including ﬁbronectin (FN), collagen (COL), elastin (ELN), and pro-
teoglycans as well as plasminogen activator inhibitor-1 (PAI1) and
tissue inhibitor of metalloproteinase-1 (TIMP1) (Fuchshofer and
Tamm, 2012). PAI-1 and TIMP-1 suppress proteolytic degradation
of the ECM (Fuchshofer and Tamm, 2012). In addition, TGFb2 in-
creases expression of the ECM cross-linking enzymes
transglutaminase-2 (TGM2) (Tovar-Vidales et al., 2008; Welge-
Lussen et al., 2000), lysyl oxidase (LOX), and LOX like 1e4
(LOXL1e4) (Sethi et al., 2011b). Thus, parallels can be easily drawnts reserved.
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mediated ﬁbrosis that occurs in other cells and tissues.
We have previously reported that TM cells express several
members of the bone morphogenetic (BMP) family, including BMP
ligands (BMP2, BMP4, BMP5 and BMP7), BMP receptors (BMPR1a,
BMPR1b, BMPR2), and BMP antagonists such as gremlin
(Wordinger et al., 2002, 2007). BMPs are members of the TGFb
superfamily of proteins that control multiple functions in a variety
of cell types. Interestingly, BMP4 and BMP7 block the TGFb2-
induction of a variety of ECM proteins in TM cells, including
ﬁbronectin, collagens IV & VI, TSP-1, and PAI1 (Fuchshofer et al.,
2007; Wordinger et al., 2007).
BMP antagonists, such as gremlin, tightly regulate BMP cellular
activity. Gremlin directly binds to speciﬁc BMP ligands and blocks
BMP binding to their receptors (Wordinger et al., 2008). We have
reported greater levels of gremlin in glaucomatous TM cells and
tissues (Wordinger et al., 2007). Elevated gremlin levels also occur
in ﬁbrotic disease of the kidney (Wordinger et al., 2008). We pre-
viously reported that gremlin antagonized BMP4 inhibition of
TGFb2-induced ECM proteins like FN and PAI1 in TM cells and also
elevated IOP in perfusion cultured human anterior segments
(Wordinger et al., 2007). Recently, we also demonstrated that
gremlin alone can induce ﬁbrosis-like activities in TM cells. Gremlin
induced expression of FN, COL1, ELN and PAI1 genes and proteins in
cultured TM cells utilizing the TGFb2/SMAD signaling pathway
(Sethi et al., 2011a).
The LOX family contains 5 genes, LOX and LOXL1e4, encoding
enzymes that covalently cross-link elastin and collagens via gen-
eration of aldehydes on lysine residues. This cross-linking reaction
provides additional mechanical strength to the ECM and alsomakes
the ECM more resistant to degradation. LOX and LOXL are associ-
ated with several abnormalities related to an imbalance in ECM
synthesis and/or degradation such as ﬁbrotic disorders of connec-
tive tissues of the heart (atrial ﬁbrosis and myocardial ﬁbrosis),
vasculature (atherosclerosis, vascular aneurysms and arterial
ﬁbrosis), lungs (pulmonary ﬁbrosis), skin (ﬁbrosis, hypertrophic
scarring, keloids, and scleroderma), kidney (diabetic nephropathy,
nephritis), liver (liver stiffness preceding liver ﬁbrosis), mouth
(inﬂamed oral tissue, gingival atrophy), and colon (intestinal
ﬁbrotic disease) (Sethi et al., 2012). The TM expresses enzymatically
active LOX and LOXL proteins, and TGFb2 utilizes both canonicalSMAD as well as c-Jun N-terminal Kinase (JNK) signaling pathways
to induce LOX genes and proteins in cultured human TM cells (Sethi
et al., 2011b). Both SMAD and mitogen activated protein kinase
(MAPK) signaling pathways, including JNK signaling, have been
associated with ﬁbrosis (Ma et al., 2009). However, very little is
known about the role of gremlin and the signaling mechanism(s)
used to induce LOX and LOXL.
The purpose of the present study was to determine: (1) whether
gremlin induces LOX gene expression in the TM cells, and (2) which
signaling pathway(s) regulate gremlin-induced LOX expression in
the TM.
2. Materials and methods
2.1. TM cell culture
Human TM cells were isolated from carefully dissected human
TM tissue explants derived from donor eyes and characterized as
previously described (Fleenor et al., 2006; Wordinger et al., 2002,
2007). All donor tissues were obtained from regional eye banks
and managed according to the guidelines in the Declaration of
Helsinki for research involving human tissue. Isolated TM cells
were grown in Dulbecco’s modiﬁed Eagle’s medium (DMEM;
Invitrogen-Gibco, Grand Island, NY) containing L-glutamine
(0.292 mg/ml; Gibco BRL Life Technologies), penicillin (100 units/
ml)/streptomycin (0.1 mg/ml); (Gibco BRL Life Technologies), and
10% fetal bovine serum (Gibco BRL Life Technologies).
2.2. TM cell treatments
TM cells were grown to 100% conﬂuency and then kept in
serum-free medium for 24 h prior to gremlin or inhibitor treatment
to avoid the confounding effects of serum proteins. TM cells were
incubated with fresh medium containing speciﬁc signaling in-
hibitors for 1e6 h, prior to the addition of varying concentrations of
recombinant gremlin protein (R&D System, Minneapolis, MN).
Small molecule inhibitors LY364947 (5 mM, Tocris biosciences,
Ellisville, MO) and SB431542 (5 mM, SigmaeAldrich, St. Louis, MO)
were used to examine the effects of inhibition of TGFb Receptor-1/2.
SMAD-3 phosphorylation inhibitor SIS3 (10 mM, SigmaeAldrich, St.
Louis, MO), JNK inhibitor SP600125 (10 mM, SigmaeAldrich, St.
Louis, MO), and p38 MAPK inhibitor SB203580 (5 mM, Tocris Bio-
sciences, Ellisville, MO) were used to examine effects of inhibition
on canonical SMAD, JNK, and p38 signaling pathways, respectively
(Sethi et al., 2011b).
2.3. RNA isolation
Total cellular RNA was extracted from cultured TM cells using
TRI Reagent RT extraction (MRC Inc., Cincinnati, OH), and the Su-
perScript VILO cDNA Synthesis kit (Invitrogen) was used for ﬁrst
strand cDNA synthesis. PCR primers for the various LOX genes
were designed using Primer3 software (http://frodo.wi.mit.edu/
primer3/). The primer pairs are listed in Table 1.
2.4. Quantitative real time PCR
Real-time PCR was performed as described previously (Sethi
et al., 2011b). Brieﬂy, 2.5 ml of cDNA was used in a reaction con-
sisting of 1.5 units per reaction of antibody-bound Taq enzyme
(Jump Start; SigmaeAldrich, St. Louis, MO), 10 PCR buffer, 1.5 mM
MgCl2, 200 nM dNTP mix, 100 nM PCR primers (Table 1), 2.5 ml
green nucleic acid dye (EvaGreen; Biotium, Hayward, CA), as well as
30 nM passive reference dye (Rox; USB, Cleveland, OH) per 50-ml
reaction. PCR was performed on a real-time thermal cycler (model
Table 1
List of the primers used for PCR studies.
Gene Primer (50 / 30)
LOX Left CGACCCTTACAACCCCTACA
Right AAGTAGCCAGTGCCGTATCC
LOXL1 Left AGAGCCTCTCTGTCCACCAG
Right GTACACCTGCCCGTTGTTCT
LOXL2 Left CCTGGGGAGAGGACATACAA
Right CTCGCAGGTGACATTCTTCA
LOXL3 Left CAACGCGGCCTTCTACAG
Right GGTGTCATTGGCACGATAGA
LOXL4 Left CGACAGCCACTACTACAGGAAA
Right CTGGTGGATCCAGAAGGAGTT
GAPDH Left CCACCCATGGCAAATTCCATGGCA
Right TCTAGACGGCAGGTCAGGTCCACC
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initial denaturation at 95 C; 40 cycles of 95 C for 30 s, 60 C for
30 s, and 72 C for 60 s, and a denaturation cycle for the creation of a
dissociation curves. Reactions for each sample were run in dupli-
cate, cycle thresholds (Ct) were normalized to GAPDH expression as
a housekeeping gene, and comparative quantitationwas performed
using MxPro ver. 4.0 software (Stratagene). The delta delta Ct
methodwas used for quantiﬁcation of the data. Only individual PCR
samples with single-peak dissociation curves were selected for data
analysis.
2.5. Protein extraction and western blot analysis
Secreted proteins: LOX proteins secreted by TM cells were
determined bywestern immunoblot analysis. Conditionedmedium
was collected from human TM cells after 24-h treatment with
gremlin in serum-free medium containing 0.5 mg/ml BSA. Proteins
were separated on a 10% denaturing polyacrylamide gel and
transferred by electrophoresis to a PVDF membrane. Membranes
were blocked with 5% Fat-free Dry Milk in tris-buffered saline
tween buffer (TBST) for 1 h and then incubated overnight with
primary antibodies (Table 2). The membranes were washed with
TBST and processed with corresponding horseradish peroxidase-
conjugated secondary antibodies (Table 2). The proteins were
then visualized in a Fluor ChemTM 8900 imager (Alpha Innotech,
San Leandro, CA) using ECL detection reagent SuperSignal West
Femto Maximum Sensitivity Substrate (Pierce Biotechnology
Rockford, IL).
Cell-associated proteins: Total cellular protein was extracted
from TM cells using mammalian protein extraction buffer (MPER,
Pierce Biotechnology), containing protease inhibitor (Pierce
Biotechnology) and phosphatase inhibitor (Pierce Biotechnology)
cocktails. Protein concentration was determined using the Bio-Rad
Dc protein assay system (Bio-Rad Laboratories, Richmond, CA). The
cellular proteins were separated on denaturing polyacrylamide gels
and then transferred to PVDF membranes by electrophoresis. BlotsTable 2
List of antibodies used for western immunoblotting studies.
Antibody Ab. Dilution Source
Rabbit anti-LOX 1:10,000 Novus Biologicals (Cat. # NB100-2530)
Rabbit anti-LOXL1 1:500 Abnova (Cat. # H00004016-D01P)
Mouse anti-LOXL2 1:2000 R&D Systems (Cat. # MAB2639)
Rabbit anti-LOXL3 1:1000 SigmaeAldrich (Cat # SAB2107508)
Mouse anti-LOXL4 1:250 Abcam (Cat. # ab25904)
Rabbit anti-GAPDH 1:1000 Cell Signaling (Cat. # 2118)
Donkey anti-mouse IgG 1:10,000 Santa Cruz Biotechnology (Cat. # sc-2314)
Goat anti-rabbit IgG 1:10,000 Santa Cruz Biotechnology (Cat. # sc-2004)were blocked with 5% Fat-free Dry Milk in TBST for 1 h and then
incubated overnight with primary antibodies (Table 2). The mem-
branes were washed with TBST and processed with corresponding
horseradish peroxidase-conjugated secondary antibodies (Table 2).
The proteins were then visualized in a Fluor ChemTM 8900 imager
(Alpha Innotech) using ECL detection reagent SuperSignal West
Femto Maximum Sensitivity Substrate (Pierce Biotechnology). To
ensure equal protein loading, the same blot was subsequently
developed for GAPDH expression.
2.6. Statistical analysis
For comparing results between two groups, the two-tailed
student’s t test was performed. One-way ANOVA was employed
for comparison of results between more than two groups.
3. Results
3.1. Gremlin induces LOX mRNA and protein expression in TM cells
We previously reported that gremlin induces the ECM proteins
FN, COL1, PAI1 and ELN in TM cells (Sethi et al., 2011a). Therefore,
we ﬁrst determined the effect of gremlin on LOX and LOXL
expression. Treatment with gremlin (1 mg/ml) for 24 h signiﬁcantly
induced LOX and LOXL1e4 mRNA expression (n ¼ 3, p < 0.05)
(Fig. 1A). Gremlin also induced protein expression of cell associated
and secreted LOX, LOXL1, LOXL2, and LOXL4 in cell lysates (Fig. 1B
and D) and conditioned medium (Fig. 1C and E). LOXL3 was not
assayed due to lack of a commercially consistently reliable
antibody.
3.2. Gremlin induces LOX genes and proteins in a concentration-
and time-dependent fashion
TM cell strains (n ¼ 3) were treated with increasing concen-
trations of gremlin (0e2 mg/ml) for 24 h. The mRNA and protein
expression of LOX and LOXL1e4 were determined using qRT-PCR
and western immunoblotting, respectively. Gremlin induced the
expression of all 5 LOX genes (Fig. 2A), as well as cell-associated
(Fig. 2B and D) and secreted LOX proteins (Fig. 2C and E) in a
concentration-dependent manner. TM cells were also treated with
gremlin for 6,12 and 24 h to determine the time dependence of LOX
and LOXLmRNA induction. Gremlin signiﬁcantly (p< 0.01) induced
LOX and LOXL mRNA expression, although the time course of in-
duction varied for each gene (Fig. 3A). By six hours, gremlin
signiﬁcantly induced all LOX genes except LOXL3. Similarly, TM cell
strains (n ¼ 3) were treated with gremlin (1 mg/ml) for 3, 6, 12, 24
and 48 to evaluate the effects of exogenous gremlin on LOX protein
expression. Gremlin induced both cell-associated (Fig. 3B and D)
and secreted (Fig. 3C and E) LOX proteins as early as 6 h and
maintained this induction for up to 48 h. We were unable to get
consistent western immunoblot results for LOXL3. The gremlin
induction of LOXL2 and LOXL4 proteins peaked as soon as 3 h and
was maintained at 48 h. Therefore, gremlin induction of LOX and
LOXL mRNA and proteins was both time and concentration
dependent.
3.3. TGFb signaling in gremlin induction of LOX proteins
We previously used various small molecule inhibitors to explore
the involvement of TGFb signaling pathway(s) in gremlin-mediated
ECM induction. We discovered that gremlin utilizes TGFb receptors
to induce ECM proteins (Sethi et al., 2011a). We employed a similar
approach to study the role of TGFb receptors/signaling pathways in
regulating gremlin induction of LOX and LOXL proteins. SB431542 is
Fig. 1. Gremlin induces LOX mRNA and proteins in TM cells. (A) Induction of LOX, LOXL1, LOXL2, LOXL3 and LOXL4 mRNA in six TM cell strains treated with gremlin (1 mg/ml) for
24 h vs. untreated control samples. Values represent the fold induction of LOX genes normalized to GAPDH. Three replicates of each sample were employed. Gremlin signiﬁcantly
induced all 5 LOX genes in all the six cell lines. (BeC) Western immunoblots of cell-associated (B) and secreted (C) LOX, LOXL1, LOXL2 and LOXL4 proteins in two TM cell strains
treated with gremlin (1 mg/ml) for 24 h. Cell-associated LOX proteins were normalized to GAPDH (B), while equal volumes of conditioned medium were loaded for secreted LOXs
(C). Gremlin increased the expression of both cell associated and secreted LOXs. Similar results were observed in four additional TM cell strains. The western blot images are
representative of three independent experiments. (DeE) Densitometry analysis of western immunoblots for cell associated (D) and secreted (E) LOXs. Two-tailed student’s t test
was used to compare control and gremlin-treated samples **0.0001 < p < 0.01 and ***p < 0.0001.
Fig. 2. Concentration-dependent gremlin-induction of LOX mRNA and proteins. Concentration dependent induction of LOX mRNA (A), cell-associated protein (B), and secreted
proteins (C) by 0e2 mg/ml gremlin in cultured TM cell strains (n ¼ 3). qRT-PCR values (A) represent fold LOX induction normalized to GAPDH and compared to controls. Three
replicates of each sample were employed. Each line represents the individual LOX gene. Concentration dependent induction of cell associated (B) and secreted LOX proteins (C) by
0e2 mg/ml gremlin in cultured TM cell strains. Similar results were observed in two additional TM cell strains. The western blot images are representative of two independent
experiments in each TM cell strain. (DeE) Densitometry analysis of western immunoblots for cell associated (D) and secreted (E) LOXs are plotted as lines. One-Way ANOVA was
used for statistical analyses for comparing the samples. *0.01 < p < 0.05, **0.0001 < p < 0.01 and ***p < 0.0001.
Fig. 3. Time-dependent gremlin-induction of LOX proteins. Time course induction (0e48 h) of LOX mRNA (A), cell-associated proteins (B), and secreted LOX proteins (C) after
treatment of cultured TM cell strains (n ¼ 3) with gremlin (1 mg/ml). qRT-PCR values (A) represent fold LOX induction normalized to GAPDH compared to controls. Three replicates
of each sample were employed for qRT-PCR. Each line represents the individual LOX gene. Time dependent induction of cell associated (B) and secreted LOX proteins (C) by gremlin
in cultured TM cell strains. Similar results were observed in two additional TM cell strains. The western blot images are representative of two independent experiments in each TM
cell strain. GAPDH served as loading control (B), while equal volumes of conditioned medium were used for secreted proteins (C). (DeE) Densitometry analysis of western im-
munoblots for cell associated (D) and secreted (E) LOXs are plotted as continuous lines. One-Way ANOVA was used for statistical analyses for comparing the samples.
*0.01 < p < 0.05, **0.0001 < p < 0.01 and ***p < 0.0001.
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is relatively more selective for the TGFBR2 receptor than the
TGFBR1 receptor. We pretreated TM cell strains (n ¼ 3) for 1 h with
or without 5 mMSB431542 or LY364947 followed by treatment with
recombinant gremlin (1 mg/ml) for 24 h. Gremlin elevated cell-
associated and secreted LOX and LOXL protein expression
compared to untreated or inhibitor only-treated samples. Pre-
treatment with either of the two inhibitors, LY364947 (Fig. 4) or
SB431542 (Fig. 5) blocked gremlin-mediated LOX induction in all
TM cell strains tested (p < 0.001). Treatment with the inhibitors
alone did not have any effect on the expression of LOX or LOXL
proteins. The inhibitors alone or in combination with gremlin also
did not affect the health of TM cells as measured by LDH cytotox-
icity assay (Data not shown).
We also previously reported that gremlin induced phosphory-
lation of SMAD2 and SMAD3 proteins within 15 min in TM cells and
maintained this phosphorylation up to 4 h. SMAD2 and 3 together
or individually form a complex with co-SMAD4 to regulate tran-
scription of target genes (Shi and Massague, 2003). To determine
whether SMAD3 transcriptionally regulates LOX proteins, we
employed SIS3, a selective small molecule inhibitor of SMAD3.
Three TM cell strains were pretreated with SIS3 (10 mM) six hours
prior to treating with recombinant gremlin for an additional 24 h to
study the expression of LOX and LOXL proteins. Untreated cells and
SIS3 alone treated cells served as negative controls. Gremlin-
induction of cell-associated (Fig. 6A and C) and secreted (Fig. 6B
and D) LOX protein expression was inhibited by SIS3 pretreatment.
Therefore, we concluded that gremlin induction of LOXs is medi-
ated by SMAD3 signaling.We previously demonstrated that TGFb2 utilizes the JNK
signaling pathway to regulate LOX and LOXL induction in TM cells
(Sethi et al., 2011b). Therefore, we wanted to test whether gremlin
also utilizes MAPK signaling pathways to regulate LOX protein
expression. We used SP600125, a selective small molecule inhibitor
of JNK, to determine the potential role of the JNK signaling pathway
in gremlin-induction of LOX proteins. Three TM cell strains were
pretreated with SP600125 (10 mM) for one hour prior to treating
with recombinant gremlin for an additional 24 h. Untreated cells
and SP600125-alone treated cells served as negative controls.
Gremlin-induction of cell-associated (Fig. 7A and C) and secreted
(Fig. 7B and D) LOX and LOXL1 protein expression was inhibited by
SP600125 pretreatment. However, SP600125 only mildly blocked
gremlin induction of cell-associated LOXL2 and LOXL4 proteins, but
did not affect their secreted forms.
TGFb2 also phosphorylates and activates p38 MAPK in cultured
TM cells as early as 15min andmaintains this phosphorylation state
for 4 h (Sethi et al., 2011b). To determine whether the p38 pathway
regulates LOX protein expression, we employed SB203580, a se-
lective small molecule inhibitor of p38. Three TM cell strains were
pretreated with SB203580 (10 mM) for one hour prior to treating
with recombinant gremlin for an additional 24 h. Untreated cells
and SB203580-alone treated cells served as negative controls.
Gremlin-induction of cell-associated LOXL1 and LOXL4 proteins
was completely inhibited by SB203580 pretreatment (Fig. 8A and
C). SB203580 mildly decreased gremlin induction of LOX and only
marginally blocked gremlin-induced LOXL2. SB203580 also blocked
gremlin induction of secreted LOXL1, LOXL2 and LOXL4 proteins and
had little effect on blocking LOX secretion (Fig. 8B and D).
Fig. 4. TGFb receptor II inhibitor LY364947 blocks gremlin-induction of LOX proteins. Western immunoblots determining the effect of TGFBR inhibitor LY364947 on gremlin in-
duction of cell-associated (A) and secreted (B) LOX proteins. Western immunoblots of TM cells pretreated with 5 mM of LY364947 followed by treatment with 1 mg/ml of gremlin for
24 h. Untreated and inhibitor only treated cells served as negative controls. GAPDH was used as a loading control for cell associated proteins. Blots shown are representative data
obtained in one TM strain. The experiment was performed independently two times in three different TM cell strains. (CeD) Densitometry analysis of western immunoblots for cell
associated (C) and secreted (D) LOXs are plotted as bar graphs. Two-tailed student’s t test was used to compare gremlin- and gremlin þ LY364549-treated samples. ***p < 0.0001.
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Fig. 5. TGFb receptor I/II inhibitor SB431542 blocks gremlin-induction of LOX proteins. Western immunoblots determining the effect of TGFBR inhibitor SB431542 on gremlin
induction of cell-associated (A) and secreted (B) LOX proteins. Western immunoblots of TM cells pretreated with 5 mM of SB431542 followed by treatment with 1 mg/ml of gremlin
for 24 h. Untreated and inhibitor only treated cells served as negative controls. GAPDH was used as loading control for cell associated proteins. Blots shown are representative data
obtained in one TM strain. The experiment was performed independently two times in three different TM cell strains. (CeD) Densitometry analysis of western immunoblots for cell
associated (C) and secreted (D) LOXs are plotted as bar graphs. Two-tailed student’s t test was used to compare gremlin- and gremlin þ SB431542-treated samples.
**0.0001 < p < 0.01, ***p < 0.0001.
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proteins in TM cells, which may have signiﬁcant implications in
ﬁbrosis and glaucoma pathogenesis.
4. Discussion
LOX and LOXL oxidize peptidyl lysine and hydroxylysine resi-
dues in collagen and lysine residues in elastin to produce peptidyl
alpha-aminoadipic-delta-semialdehydes. These aldehyde residues
can spontaneously combinewith vicinal peptidyl aldehydes or with
epsilon-amino groups of peptidyl lysine to form the covalent cross-
links that stabilize and decrease the solubility of ﬁbrillar collagen
and elastin ﬁbers in the ECM (Kagan and Li, 2003). Also, LOX and
LOXL are involved in several connective tissue ﬁbrotic diseases
(Sethi et al., 2012). It is likely that these enzymes also play a crucial
role in other ﬁbrotic diseases such as glaucoma.
Elastin and collagen proteins are elevated in the glaucomatous
TM (Acott and Kelley, 2008), and a recent report used atomic force
microscopy to demonstrate that glaucomatous TM tissues were
signiﬁcantly stiffer than the TM from non-glaucoma eyes (Last
et al., 2011). Greater cross-linking of ECM proteins within the
TM could lead to greater tissue stiffness. Overexpression of pro-
ﬁbrotic molecules like TGFb2 has been shown to increase ECM
crosslinking (Sethi et al., 2011b; Tovar-Vidales et al., 2011; Welge-
Lussen et al., 2000).Gremlin’s role in development and in several ﬁbrotic diseases is
quite well known. It is not uncommon to ﬁnd developmental genes
re-expressed in pathological conditions, including cancer and
inﬂammation. Prior to this work, our understanding of gremlin’s
involvement in TM ﬁbrosis is currently limited to TGFb signaling-
mediated gremlin induction of ECM proteins (Sethi et al., 2011a).
However, the role of gremlin in regulating ECM crosslinking has not
been studied previously.
Our current results demonstrate that exogenous gremlin in-
duces mRNA and protein expression of LOX and LOXL genes in
multiple TM cell strains. We also demonstrated that gremlin uti-
lizes the TGFb signaling pathway to regulate LOX and LOXL proteins
and that both the canonical SMAD as well as non-SMAD JNK1/2 and
p38 MAPK signaling pathways are involved in this gremlin induc-
tion. The results have been illustrated in Fig. 9, which suggests that
gremlin functions by inhibiting the endogenous BMP antagonism of
TGFb signaling in cultured TM cells. This leads to LOX and LOXL
induction. These data highlight the signiﬁcance of ECM cross-
linking by BMP antagonists like gremlin in the TM cells and high-
light that perturbations of the TGFbeBMP signaling pathways
regulation of the ECM environment may lead to TM ﬁbrosis and
glaucoma. Since TGFb and BMP pathways are endogenously active
in TM cells (Wordinger et al., 2002, 2007), the data raise important
questions about the existence and regulation of a plethora of
downstream players including other intracellular and extracellular
Fig. 6. SMAD3 inhibitor SIS3 blocks gremlin-induction of LOX proteins. Representative western immunoblots of SMAD3 inhibitor SIS3 effects on gremlin induction of cell-associated
(A) and secreted (B) LOX proteins. Western immunoblots of TM cells pretreated with 10 mM of SIS3 followed by treatment with 1 mg/ml of gremlin for 24 h. Untreated and inhibitor
only treated cells served as negative controls for cell-associated proteins. GAPDH was used as loading control for cell associated proteins. Blots shown are representative data
obtained in one TM strain. The experiment was performed independently two times in three different TM cell strains. (CeD) Densitometry analysis of western immunoblots for cell
associated (C) and secreted (D) LOXs are plotted as bar graphs. Two-tailed student’s t test was used to compare gremlin- and gremlin þ SIS3-treated samples. **0.0001 < p < 0.01,
***p < 0.0001.
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Fig. 7. JNK inhibitor SP600125 blocks gremlin-induction of several LOX proteins. Representative western immunoblots on the effect of JNK inhibitor SP600125 on gremlin induction
of cell-associated (A) and secreted (B) LOX proteins. Western immunoblots of TM cells pretreated with 10 mM of SP600125 followed by treatment with 1 mg/ml of gremlin for 24 h.
Untreated and inhibitor only treated cells served as negative controls. GAPDH was used as loading control for cell associated LOXs. Blots shown are representative data obtained in
one TM strain. The experiment was performed independently two times in three different TM cell strains. (CeD) Densitometry analysis of western immunoblots for cell associated
(C) and secreted (D) LOXs are plotted as bar graphs. Two-tailed student’s t test was used to compare gremlin- and gremlin þ SP600125-treated samples. **0.0001 < p < 0.01,
***p < 0.0001.
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Fig. 8. p38 MAPK inhibitor SB203580 blocks gremlin-induction of several LOX proteins. Representative western immunoblots of p38 MAPK inhibitor SB203580 effects on gremlin
induction of cell-associated (A) and secreted (B) LOX proteins. Western immunoblots of TM cells pretreated with 10 mM of SB203580 followed by treatment with 1 mg/ml of gremlin
for 24 h. Untreated and inhibitor only treated cells served as negative controls. GAPDH was used as loading control for cell associated LOXs. Blots shown are representative data
obtained in one TM strain. The experiment was performed independently two times in three different TM cell strains. (CeD) Densitometry analysis of western immunoblots for cell
associated (C) and secreted (D) LOXs are plotted as bar graphs. Two-tailed student’s t test was used to compare gremlin- and gremlin þ SB203580-treated samples.
**0.0001 < p < 0.01, ***p < 0.0001.
Fig. 9. Proposed mechanism of gremlin regulation of LOXs in TM. Gremlin blocks BMP signaling pathway, which is unable to inhibit the endogenous TGFb signaling in TM cells. The
endogenously active TGFb pathway can activate Smad, P38 and JNK pathways to induce different LOX genes and proteins in TM cells.
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A. Sethi et al. / Experimental Eye Research 113 (2013) 117e127 127proteins that are involved in maintaining TM homeostasis, distur-
bance of which may lead to diseases like glaucoma.
We have previously reported that both TGFb2 and gremlin
phosphorylate and activate SMAD2/3 signaling in TM cells.
Knocking down the SMAD signaling pathway blocked TGFb2 in-
duction of LOX and LOXL (Sethi et al., 2011b). By blocking SMAD
signaling with SIS3, we also observed that gremlin induction of LOX
proteins is inhibited. These data not only imply that gremlin em-
ploys the canonical SMAD pathway to regulate LOXs, but also em-
phasizes the proﬁbrotic effects of SMAD signaling in the TM. We
have previously observed that TM cells maintain basal phosphor-
ylation levels of both JNK and p38MAPK (Sethi et al., 2011a, 2011b).
Crosstalk and interaction between SMAD and MAPK pathways
has been observed in several cell types and in a variety of normal
and pathological conditions (de la Cruz-Merino et al., 2009; Jav-
elaud and Mauviel, 2005). Our data indicate that the basal level of
MAPK kinase activity may be important in regulating LOX and LOXL
in TM cells. Whether the basal MAPK kinase activity regulates LOX
enzymatic activity is a question that needs to be addressed.
Several additional questions are raised by our current results.
First, it was surprising to ﬁnd that all 5 LOX family genes are
induced by gremlin. The LOX and LOXL enzymesmay have different
speciﬁc roles in the TM including differences in substrate speciﬁcity
and/or speciﬁc localization patterns. The potential relationship
between the LOX proteins in regulating AH outﬂow in gremlin-
induced ocular hypertension and POAG is not known. It is also
not clear which LOX protein is important for normal TM homeo-
stasis and if any of the LOX proteins are directly involved in path-
ogenesis of glaucoma. Future in vivo studies are needed to address
this question. The role of MAPK signaling in TM ﬁbrosis and in
regulating TM LOX enzymatic activity also needs further study. Our
current results provide a foundation to address these issues in
future studies.
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